Wells Fargo’s XBiotech XBIT Stock Holding History

Wells Fargo’s Portfolio XBIT Stock Details XBIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-149	Closed	-$443	–	7432
2025 Q2	$443	Sell	149 -11,816	-99%	-$34.4K	﹤0.01%	6387
2025 Q1	$38.8K	Buy	11,965 +264	+2%	+$910	﹤0.01%	5480
2024 Q4	$46.2K	Buy	11,701 +2,548	+28%	+$17.4K	﹤0.01%	5513
2024 Q3	$70.8K	Buy	9,153 +1,024	+13%	+$6.73K	﹤0.01%	5204
2024 Q2	$41.8K	Buy	8,129 +7,974	+5,145%	+$61.5K	﹤0.01%	5357
2024 Q1	$1.26K	Buy	155 +3	+2%	+$17	﹤0.01%	6100
2023 Q4	$608	Buy	152 +8	+6%	+$32	﹤0.01%	6339
2023 Q3	$593	Buy	144 +17	+13%	+$85	﹤0.01%	6329
2023 Q2	$754	Buy	127 +5	+4%	+$23	﹤0.01%	6395
2023 Q1	$421	Buy	122 +2	+2%	+$7	﹤0.01%	6599
2022 Q4	$421	Buy	120 +3	+3%	+$10	﹤0.01%	6431
2022 Q3	$0	Buy	117 +15	+15%	+$71	﹤0.01%	7482
2022 Q2	$1K	Sell	102 -21,013	-100%	-$141K	﹤0.01%	6637
2022 Q1	$182K	Sell	21,115 -16,167	-43%	-$162K	﹤0.01%	5031
2021 Q4	$415K	Sell	37,282 -110,165	-75%	-$1.43M	﹤0.01%	4807
2021 Q3	$1.91M	Sell	147,447 -63,037	-30%	-$1M	﹤0.01%	3707
2021 Q2	$3.49M	Sell	210,484 -17,033	-7%	-$289K	﹤0.01%	3199
2021 Q1	$3.91M	Buy	227,517 +113,382	+99%	+$2.12M	﹤0.01%	3075
2020 Q4	$1.79M	Buy	114,135 +41,801	+58%	+$770K	﹤0.01%	3579
2020 Q3	$1.38M	Buy	72,334 +14,338	+25%	+$247K	﹤0.01%	3615
2020 Q2	$795K	Buy	57,996 +44,465	+329%	+$625K	﹤0.01%	3995
2020 Q1	$144K	Sell	13,531 -2,688	-17%	-$43.8K	﹤0.01%	4875
2019 Q4	$303K	Buy	16,219 +6,611	+69%	+$85.1K	﹤0.01%	4721
2019 Q3	$100K	Buy	9,608 +8,482	+753%	+$69.1K	﹤0.01%	5318
2019 Q2	$9K	Buy	1,126 +126	+13%	+$1.1K	﹤0.01%	5941
2019 Q1	$11K	Sell	1,000 -4,000	-80%	-$32.4K	﹤0.01%	5627
2018 Q4	$25K	Hold	5,000	–	–	﹤0.01%	5721
2018 Q3	$16K	Sell	5,000 -60	-1%	-$234	﹤0.01%	5885
2018 Q2	$22K	Sell	5,060 -9,778	-66%	-$44.2K	﹤0.01%	5795
2018 Q1	$80K	Buy	14,838 +4,051	+38%	+$18.7K	﹤0.01%	5404
2017 Q4	$42K	Sell	10,787 -3,339	-24%	-$14.1K	﹤0.01%	5605
2017 Q3	$61K	Buy	14,126 +1,055	+8%	+$4.98K	﹤0.01%	5404
2017 Q2	$61K	Buy	13,071 +1,290	+11%	+$12.4K	﹤0.01%	5340
2017 Q1	$194K	Hold	11,781	–	–	﹤0.01%	4827
2016 Q4	$119K	Buy	11,781 +5,881	+100%	+$78.2K	﹤0.01%	5063
2016 Q3	$79K	Hold	5,900	–	–	﹤0.01%	5051
2016 Q2	$123K	Buy	5,900 +5,618	+1,992%	+$81.1K	﹤0.01%	4694
2016 Q1	$2K	Buy	282 +256	+985%	+$2.12K	﹤0.01%	6048
2015 Q4	$0	Buy	26 +2	+8%	+$26	﹤0.01%	6451
2015 Q3	$0	Sell	24 -178	-88%	-$3.12K	﹤0.01%	6488
2015 Q2	$4K	Buy	+202	New	+$4.19K	﹤0.01%	6061

Other funds holding XBIT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Wells Fargo's XBIT Position: Q3 2025 in Review

Wells Fargo sold out of XBiotech (XBIT) in Q3 2025, closing a stake of 149 shares — an estimated $443 sold.

Wells Fargo first reported a position in XBIT in Q2 2015 and held it in 41 quarters. The position peaked at $3.91M in Q1 2021. 48 funds tracked by Wall St. Rank hold XBIT as of Q3 2025.

Wells Fargo reported no remaining XBiotech position as of Q3 2025 after selling out during the quarter.
Wells Fargo sold 149 XBiotech shares in Q3 2025, an estimated $443.
Wells Fargo first reported a position in XBiotech in Q2 2015 and held it in 41 quarters.
Wells Fargo's XBiotech position peaked at $3.91M in Q1 2021.
48 funds tracked by Wall St. Rank held XBiotech as of Q3 2025.

Based on Wells Fargo's 13F filing for Q3 2025, filed 13 Nov 2025.